Home » Authors » Jim Shrine

Articles by Jim Shrine

European Sector Rallying Cry: Comebacks, Consolidation

March 12, 2003

Companies Urged To Shore Up Until Sector Regains Favor

Sep. 11, 2002

Companies Urged To Shore Up Until Sector Regains Favor

Sep. 11, 2002

European Biotech Struggling, Industry Waiting For Upswing

Sep. 10, 2002

European Biotech Struggling, Industry Waiting For Upswing

Sep. 10, 2002

Finding Hot’ Biotech Investments Still Means Looking At Leaders

March 21, 2002

Finding Hot’ Biotech Investments Still Means Looking At Leaders

March 21, 2002

Investors In Tight Market Looking At Hybrid Platform/Product Firms

March 20, 2002

Investors In Tight Market Looking At Hybrid Platform/Product Firms

March 20, 2002

Large-Cap Companies Doing Well In Maturing Industry s Bifurcation

Jan. 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...